Why Covaxin is yet to win WHO’s emergency approval?

GS Paper 2 Topics Covered: Issues related to health.   Context: The World Health Organization’s (WHO’s) approval for WHO pre-qualification, or Emergency Use Listing (EUL) for Bharat Biotech International Ltd’s covid-19 vaccine is moving according to procedure and the Indian government’s haste in pushing through the process is only adding to speculation about the alleged delay. …

WHO pre-qualification, or Emergency Use Listing (EUL): 

GS Paper 2 Topics Covered: Important International institutions, agencies and fora, their structure, mandate.    Context:  The World Health Organisation (WHO) may take a decision on granting Emergency Use Listing (EUL) to Bharat Biotech’s Covaxin this week.  The vaccine should get international recognition with this. Post approval people wanting to travel abroad will not have difficulty.  …

Insights into Editorial: Whatever it takes: On govt. powers to combat vaccine hesitancy

    Context: India started its massive vaccination campaign aiming to inoculate 3 crore health and other frontline workers to start with. With the highest number of coronavirus infections after the US, India plans to vaccinate around 30 crore people with two doses in the first six to eight months of this year. Frontline workers …